Page 12 - Registration Statement News Today

Record revenue of $29.1 million, up 118% year-over-year in Q1Strong momentum in our Wallet-as-a-Service and fiat onboarding productsNYSE American uplisting scheduled for May 9th, 2024 under the ticker...

Annualized Recurring Revenue hits record $96 million, up 21% year-over-yearNet loss improved 33% year-over-year; Non-GAAP net loss improved 80% year-over-yearCash used in operating activities improved...

May 6, 2024 | First Quarter 2024 Financial Results 1 Disclaimers ...

Agilon health, inc. Investors Reminder:Kessler Topaz Meltzer & Check, ...

DevvStream Holdings Inc.   is pleased to announce that, further to its news release of September 13, 2023, it has amended certain terms of that certain Business Combination Agreement, amongst the...

367 Syngrou Avenue 175 64 P. Faliro Athens, Greece May 3, 2024 Dear Shareholder: ...

The Company's tier one leverage and risk-based capital ratios were 11.58% and 28.84%, respectively, and the Company is considered to be "well-capitalized" at March 31, 2024.Ratio of non-performing assets to total assets

Filed by Vision Sensing Acquisition Corp.Pursuant to Rule 425 under the Securities Act of 1933and deemed filed pursuant to Rule 14a-12under the Securities Exchange Act of 1934Subject Company: Vision...

Filed by Vision Sensing Acquisition Corp.

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ technology, today announced that the Company’s Board of Directors has set the...